Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financial Report: Sanofi-Aventis | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financial Report: Sanofi-Aventis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis

4Q Revenues: $8.3 billion (+7%)

4Q Earnings: $1.7 billion (+21%)

FY Revenues: $32.5 billion (+8%)

FY Earnings: $7.6 billion (+26%)

Comments: R&D expenses were up 6.6% to $1.4 billion in the quarter and up 2% to $4.8 billion for the year, representing 15% of sales for the year. Results for the quarter and full-year are based on adjusted consolidated income and excludes the material impacts of purchase accounting for the Aventis acquisition and acquisition-related integration and restructuring costs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters